MUDr. Martina Zimovjanova, Ph.D.
oncology and radiation oncology
oncology and radiation oncology
Overview
Country, City
Czechia, Prague
Health facility
General University Hospital Prague
Medical unit
Department of oncology
About the doctor
Skills & Expertise
cancer
breast
breast cancer
oncology
trastuzumab
paclitaxel
radiation
metastatic
brca1
metastatic breast
mutation
brca2
gene
her2neu
hereditary breast cancer
her2positive breast cancer
her2neu overexpressing
bone
radiation oncology
ovarian
cancer progressing
brca1 brca2 mutation
triplenegative breast cancer
ovarian cancer
digestive
drug resistance
infiltrating lymphocytes
tumor infiltrating
receptorpositive breast cancer
brca2 genes
palb2 gene
chek2 mutations
brca1 gene
5fluorouracil therapy
aromatase inhibitors
5fluorouracil
aromatase
malignant tumors
solid tumors
estrogen receptor
breast carcinoma
colorectal cancer
breast cancer predisposition
reparixin
breastsaving
estrogen
head
colorectal
carcinoma
tumor
Resume
CV (Curriculum Vitae)
Education
- Studied human medicine at the Charles University
- Obtaining a license for medical practice
- Obtaining specialization in radiation therapy
- 2002 Received additional qualifications in the field of oncology
- 2009 Habilitation and a teaching license: “Prediction of sensitivity and toxicity of fluoropyrimidines in the treatment of tumors of the digestive tract”
- 2016-2017 Certificate of the European School of Oncology of the University of Ulm
- 2019 Management skills test by the European Cancer Society
- Healthcare management program
Experience
- 1992-1995 Department of radiation therapy at the Regional Hospital in Ostrava-Poruba
- 2000 Department of oncology at the General University Hospital Prague
- 2012-2018 Regional Oncology Dispensary in Nymburk
- 2018 Head of the Department of oncology at the General University Hospital Prague
Languages
English
Czech
Publications
Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers
June, 2023
A real-world prospective observational multi-national study in adult patients with breast cancer treated with extended adjuvant neratinib: NERLYFE study
June, 2023
Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic.
8 February, 2023
Location
U Nemocnice, 499/2, 128 08 Prague, Czechia
FAQ
Where does the doctor practice?
What is the specialization of MUDr. Martina Zimovjanova, Ph.D.?
The primary specialization of the doctor is oncology and radiation oncology.
What is the experience of the specialist?
MUDr. Martina Zimovjanova, Ph.D. has been practicing for more than 32 years.
MUDr. Martina Zimovjanova, Ph.D.
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© MUDr. Martina Zimovjanova, Ph.D.